Glycated hemoglobin
Biomarker4 papers1 findingMeSH D006442
- Human trial1
- Humans2
Interventions
1SGLT2 inhibitors
downin humans1
1 study
SGLT2 inhibitors
downin humans1
SGLT2 inhibitors decrease glycated hemoglobin in humans (MD = -0.40%, 95% CI: -0.44 to -0.36).
Reviewin patients with diabetic CKD
Renoprotective effects and safety of sodium-glucose cotransporter 2 inhibitors in diabetic chronic kidney disease: A systematic review and meta-analysis · Medicine · 2 Oct 2026
Latest
16High hemoglobin glycation index is linked to stroke risk
In middle-aged and older adults, high hemoglobin glycation index was associated with incident stroke (adjusted hazard ratio 1.392), persisting after…In middle-aged and older adults, high hemoglobin glycation index was associated with incident stroke (adjusted hazard ratio 1.392), persisting after HbA1c adjustment (hazard ratio 1.333).
High HbA1c-to-HDL-C ratio linked to CVD risk in older adults
Older adults in the highest ratio quartile had a higher risk of incident cardiovascular disease than those in the lowest (HR = 2.111) over five years.Older adults in the highest ratio quartile had a higher risk of incident cardiovascular disease than those in the lowest (HR = 2.111) over five years.
Survodutide reduces weight in adults with diabetes and obesity
Weekly survodutide cut body weight by up to 9.8% at 76 weeks compared to a 3.9% reduction with placebo.Weekly survodutide cut body weight by up to 9.8% at 76 weeks compared to a 3.9% reduction with placebo.
Metformin in Elderly Patients With Type 2 Diabetes and Muscle Strength, Muscle Mass, and Physical Function: Positive or Negative Correlation?
Plant-Based Medically Tailored Groceries From a Food Pantry and Adult Cardiometabolic Outcomes
Comparative efficacy of exercise modalities on cardiometabolic health in older adults: A systematic review and network meta-analysis
GLP-1 receptor agonists link to lower stroke and Alzheimer risk
A cross-ancestry Mendelian randomization study of up to 1,812,017 individuals linked genetically proxied GLP-1 receptor agonist exposure to reduced…A cross-ancestry Mendelian randomization study of up to 1,812,017 individuals linked genetically proxied GLP-1 receptor agonist exposure to reduced risk of stroke and Alzheimer disease.